Organon & Co (OGN)
Current ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 4,508,000 | 4,050,000 | 3,958,000 | 3,780,000 | 3,931,000 | 3,592,000 | 3,774,000 | 3,719,000 | 3,760,000 |
| Total current liabilities | US$ in thousands | 2,918,000 | 2,491,000 | 2,387,000 | 2,346,000 | 2,512,000 | 2,328,000 | 2,396,000 | 2,306,000 | 2,597,000 |
| Current ratio | 1.54 | 1.63 | 1.66 | 1.61 | 1.56 | 1.54 | 1.58 | 1.61 | 1.45 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $4,508,000K ÷ $2,918,000K
= 1.54
The current ratio of Organon & Co. has shown relative stability and consistency over the past eight quarters, ranging from 1.54 to 1.66. This indicates that the company has generally maintained a healthy level of liquidity to cover its short-term obligations.
The current ratio measures the firm's ability to meet its short-term liabilities with its current assets, with a ratio above 1 indicating that the company has more current assets than current liabilities. While the current ratio has fluctuated slightly, it has generally been above 1.5, which is considered a good benchmark for liquidity.
Organon & Co. appears to have efficient management of its working capital, as evidenced by the consistent current ratio around the 1.5 to 1.6 range. This implies that the company is in a favorable position to pay off its short-term debts as they come due. Overall, the current ratio trend suggests that Organon & Co. has maintained a solid financial position in terms of liquidity management in recent quarters.
Peer comparison
Dec 31, 2023